Literature DB >> 11144451

Pulmonary tuberculosis in prisons of the ex-USSR state Georgia: results of a nation-wide prevalence survey among sentenced inmates.

A Aerts1, M Habouzit, L Mschiladze, N Malakmadze, N Sadradze, O Menteshashvili, F Portaels, P Sudre.   

Abstract

SETTING: The penitentiary system of the ex-USSR state of Georgia.
OBJECTIVES: To measure the prevalence of active pulmonary tuberculosis and drug-resistant disease among prisoners. To identify factors associated with active tuberculosis and multidrug resistance (MDR).
DESIGN: A comprehensive multiphasic screening survey for tuberculosis.
RESULTS: The prevalence of smear- or culture-positive tuberculosis was 5995 per 100,000 prisoners (n = 448 cases among 7473 inmates). Of all the strains, 215 (77.9%) were resistant to at least one drug and 37 (13.0%) were MDR. Independent risk markers associated smear- or culture-positive tuberculosis with included prison stay of 2 years or more, body mass index <20 kg/m2, accommodation in a large size prison, previous anti-tuberculosis treatment, cough of 2 weeks or more and loss of appetite. Risk markers associated with MDR were a prison stay of less than 2 years and being over 25 years of age.
CONCLUSIONS: In Georgia, the excess risk for tuberculosis among prisoners is unprecedented, suggesting that prisons represent a significant reservoir of tuberculosis. Only a comprehensive strategy for tuberculosis control in prisons, including prison reform, control of anti-tuberculosis drugs, and prompt and efficient diagnosis and treatment of patients can have an impact on the tuberculosis burden in the prison system.

Entities:  

Mesh:

Year:  2000        PMID: 11144451

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  29 in total

1.  Developing a human rights-based program for tuberculosis control in Georgian prisons.

Authors:  Medea Gegia; Iagor Kalandadze; Mikheil Madzgharashvili; Jennifer Furin
Journal:  Health Hum Rights       Date:  2011-12-15

2.  Risk factors for developing tuberculosis in remand prisons in St. Petersburg, Russia - a case-control study.

Authors:  Tatiana Lobacheva; Tommi Asikainen; Johan Giesecke
Journal:  Eur J Epidemiol       Date:  2007-03-03       Impact factor: 8.082

3.  High prevalence of multidrug-resistant tuberculosis in Georgia.

Authors:  Nino Mdivani; Ekaterina Zangaladze; Natalia Volkova; Ekaterina Kourbatova; Thea Jibuti; Natalia Shubladze; Tamar Kutateladze; George Khechinashvili; Carlos del Rio; Archil Salakaia; Henry M Blumberg
Journal:  Int J Infect Dis       Date:  2008-06-02       Impact factor: 3.623

Review 4.  Advances in the understanding of Mycobacterium tuberculosis transmission in HIV-endemic settings.

Authors:  Julian S Peters; Jason R Andrews; Mark Hatherill; Sabine Hermans; Leonardo Martinez; Erwin Schurr; Yuri van der Heijden; Robin Wood; Roxana Rustomjee; Bavesh D Kana
Journal:  Lancet Infect Dis       Date:  2018-12-13       Impact factor: 25.071

5.  Geographical heterogeneity of multidrug-resistant tuberculosis in Georgia, January 2009 to June 2011.

Authors:  H E Jenkins; M Gegia; J Furin; I Kalandadze; U Nanava; T Chakhaia; T Cohen
Journal:  Euro Surveill       Date:  2014-03-20

6.  A population-based tuberculosis contact investigation in the country of Georgia.

Authors:  D Baliashvili; R R Kempker; H M Blumberg; G Kuchukhidze; T Merabishvili; A Aslanikashvili; M J Magee
Journal:  Public Health Action       Date:  2018-09-21

7.  Negotiating "The Social" and Managing Tuberculosis in Georgia.

Authors:  Erin Koch
Journal:  J Bioeth Inq       Date:  2016-01-06       Impact factor: 1.352

8.  Prevalence of and molecular basis for tuberculosis drug resistance in the Republic of Georgia: validation of a QIAplex system for detection of drug resistance-related mutations.

Authors:  Medea Gegia; Nino Mdivani; Rodrigo E Mendes; Haijing Li; Maka Akhalaia; Jian Han; George Khechinashvili; Yi-Wei Tang
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

9.  Prevalence and risk factors for multidrug-resistant tuberculosis in the Republic of Georgia: a population-based study.

Authors:  N Lomtadze; R Aspindzelashvili; M Janjgava; V Mirtskhulava; A Wright; H M Blumberg; A Salakaia
Journal:  Int J Tuberc Lung Dis       Date:  2009-01       Impact factor: 2.373

10.  Outcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosis.

Authors:  Francine Matthys; Leen Rigouts; Vinciane Sizaire; Natalia Vezhnina; Maryvonne Lecoq; Vera Golubeva; Françoise Portaels; Patrick Van der Stuyft; Michael Kimerling
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.